Hemostatic, Metabolic, and Androgenic Risk Factors for Coronary Heart Disease in Physically Active and Less Active Postmenopausal Women
- 1 May 1995
- journal article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 15 (5) , 669-677
- https://doi.org/10.1161/01.atv.15.5.669
Abstract
Abstract Physically active postmenopausal women have a lower incidence of coronary heart disease (CHD) than their more sedentary peers, but little information is available concerning the responsible mechanisms. The primary aim of this study was to test the hypothesis that physically active postmenopausal women demonstrate more favorable levels of hemostatic, metabolic, and androgenic CHD risk factors than less active control subjects. If so, a secondary aim was to determine which of the characteristics associated with a physically active lifestyle, ie, low body fat, a high-carbohydrate/low-fat diet, high maximal aerobic capacity (aerobic fitness), and high levels of physical activity, are most closely related to this lower risk profile. To address these aims, we compared CHD risk factors in physically very active women (n=14; age, 55±2 years) with those in healthy, nonobese sedentary control subjects (n=17; age, 56±1 years). Maximal aerobic capacity (fitness) was 83% higher ( P <.001) in the physically active women. Concentrations of plasminogen activator inhibitor type 1 activity and tissue plasminogen activator antigen were lower (more favorable) ( P <.005) in the physically active women versus control subjects, whereas plasma fibrinogen levels did not differ. The physically active women had lower ( P <.01) fasting plasma insulin and glucose concentrations as well as smaller responses to an oral glucose challenge. Both total-body and abdominal fat levels were lower ( P <.001) and lipid and lipoprotein profiles were generally more favorable ( P <.05) in the physically active women. Plasma sex hormone–binding globulin concentrations were higher ( P <.01) in the physically active women, indicating a lower androgenicity-related CHD risk. In addition, the physically active women consumed a diet that was higher ( P <.002) in carbohydrates and lower ( P <.02) in fat and protein. Stepwise multiple regressions indicated that although a portion of the observed variability in these CHD risk factors can be explained by physical activity levels per se, the associated differences in total body and abdominal fat, dietary composition, and aerobic fitness also contribute in a significant but selective manner. Thirty percent to 40% of each group were on hormone replacement therapy, but its effects appeared to be minimal. These results demonstrate that physically active postmenopausal women exhibit favorable levels of hemostatic, metabolic, and androgenic CHD risk factors, which could contribute to their lower incidence of CHD.Keywords
This publication has 32 references indexed in Scilit:
- Correlation of serum lipids with the presence or absence of coronary artery disease in 1,793 men and women aged ≥ 62 yearsThe American Journal of Cardiology, 1994
- Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and womenThe American Journal of Cardiology, 1994
- Hyperandrogenicity in women—a prediabetic condition?Journal of Internal Medicine, 1993
- Inverse relationship between physical activity and plasma fibrinogen in postmenopausal womenAtherosclerosis, 1993
- Insulin resistance and compensatory hyperinsulinemia: Role in hypertension, dyslipidemia, and coronary heart diseaseAmerican Heart Journal, 1991
- Health Effects of Recreational Running in WomenSports Medicine, 1991
- A liquid-phase immunoradiometric assay (IRMA) for human sex hormone binding globulin (SHBG)The Journal of Steroid Biochemistry and Molecular Biology, 1985
- Elevated high-density lipoprotein cholesterol levels in older endurance athletesThe American Journal of Cardiology, 1984
- The Effects of Menopause and Training on Serum Lipids*International Journal of Sports Medicine, 1984
- Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamineLife Sciences, 1977